tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market
Holding COYA?
Track your performance easily

Coya Therapeutics, Inc. (COYA) Financial Statements

57 Followers

Coya Therapeutics, Inc. Financial Overview

Coya Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.719; its P/E ratio is -8.45; Coya Therapeutics, Inc. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-$ 3.43M$ 126.84K$ 6.00M-
Gross Profit-$ 3.43M$ 126.84K$ 6.00M-
EBIT$ -4.02M$ -2.89M$ -5.03M$ 2.01M$ -3.56M
EBITDA$ -4.01M$ -2.88M$ -5.02M$ 2.02M$ -3.56M
Net Income Common Stockholders$ -4.02M$ -2.89M$ -5.05M$ 1.27M$ -3.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 31.10M$ 36.60M$ 36.00M$ 32.60M$ 10.89M
Total Assets$ 35.55M$ 39.94M$ 37.39M$ 41.26M$ 11.90M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -31.10M$ -36.60M$ -36.00M$ -32.60M$ -10.89M
Total Liabilities$ 3.54M$ 4.68M$ 5.00M$ 5.63M$ 1.81M
Stockholders Equity$ 32.01M$ 35.26M$ 32.39M$ 35.64M$ 10.09M
Cash Flow-
Free Cash Flow$ -5.46M$ -4.56M$ 2.15M$ -1.89M$ -2.22M
Operating Cash Flow$ -5.46M$ -4.56M$ 2.15M$ -2.24M$ -2.22M
Investing Cash Flow--$ -25.00K$ -193.19K-
Financing Cash Flow$ -56.33K$ 5.15M$ 1.24M$ 24.17M-
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Coya Therapeutics, Inc. Debt to Assets

Coya Therapeutics, Inc. Cash Flow

Coya Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis